Records containing: Psoriasis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-07-02A Phase 1, Dose Escalation Trial to Evaluate the Safety, Tolerability and Activity of Topical Administrations of Three Different Strengths of KX01 Ointment in Patients With Plaque Type Psoriasis
-
CLINICAL_TRIALS study record update · 2025-07-01The Impact of Untreated Depression and Anxiety in Patients With Skin Diseases: A Cross-sectional Study in Jeddah
-
CLINICAL_TRIALS study record update · 2025-06-27Pharmacogenetic Observational Study Evaluating the Influence of Genetic Variants and Cardiometabolic Risk Factors on 10-Year Survival of Biologic Therapies in Patients With Cutaneous Psoriasis With or Without Psoriatic Arthritis
-
CLINICAL_TRIALS study record update · 2025-06-26Development and Testing of a Digital Psychological Tool to Improve Symptom Burden in Dermatology Patients
-
CLINICAL_TRIALS study record update · 2025-06-25A Large US Health Insurance Claims Database Will be Used to Estimate the Incidence of Serious Outcomes in Patients With Psoriasis Treated With Ustekinumab and Other Types of Biological and Systemic Non-biological Treatments
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-06-24Phase I Randomized, Open-label, Parallel-controlled, Pharmacokinetic and Safety Study of BR201 Injection Versus Cosentyx in Healthy Male Subjects
-
CLINICAL_TRIALS study record update · 2025-06-24A Phase I Clinical Study to Evaluate the Safety, Tolerability, Immunogenicity, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Oral Doses of HS-20118, and the Food Effect (FE) on the Pharmacokinetics in Adult Participants
-
CLINICAL_TRIALS study record update · 2025-06-15A Randomized Open Label Clinical Trial on the Efficacy of an Ayurvedic Treatment Package on Symptom Severity and Quality of Life in Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2025-06-12Pilot Study to Explore the Anti-Inflammatory Effects of Time-Restricted Feeding
-
CLINICAL_TRIALS study record update · 2025-06-11Psorcast Study: A Smartphone-based Study of Psoriasis and Psoriatic Arthritis
-
CLINICAL_TRIALS study record update · 2025-06-08DEVISE - Development and Evaluation of an Online Intervention to Reduce Self-stigma in People With Visible Chronic Skin Diseases: a Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-06-05Brain Morphological Changes Accompanied by Effective Biologic Treatments for Psoriasis and Their Associations With the Improvement of Well-being, Itch, and Pain
-
CLINICAL_TRIALS study record update · 2025-06-05A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Psoriasis
-
CLINICAL_TRIALS study record update · 2025-06-05Longitudinal "Real-World" Changes in Skin Microbial Ecology in Atopic Dermatitis (AD) and Psoriasis (PS) Patients
-
CLINICAL_TRIALS study record update · 2025-06-04Infliximab-Pfizer Biosimilar Post-Marketing Database Study
-
CLINICAL_TRIALS study record update · 2025-05-31A Prospective Observational Study Evaluating the Efficacy and Safety of Deucravacitinib in the Treatment of Moderate to Severe Plaque Psoriasis Patients With Eczematous Features in a Real-world Research
-
CLINICAL_TRIALS study record update · 2025-05-29Adherence to Otezla in Patients With Mild Psoriasis
-
CLINICAL_TRIALS study record update · 2025-05-25DermaFlow Alpha - Multi-modal Quantitative Imaging of the Skin
-
CLINICAL_TRIALS study record update · 2025-05-25A Phase III, Randomised, Double-blind, Multicentre Clinical Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Immunogenicity of SB17 (Proposed Ustekinumab Biosimilar) Compared to Stelara® in Subjects With Moderate to Severe Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2025-05-25Mediterranean Diet vs no Dietary Intervention for Improving Signs and Symptoms of Psoriasis in Patients Treated With Anti-IL-17 or Anti-IL-23 Inhibitors
-
CLINICAL_TRIALS study record update · 2025-05-22Psoriasis and Periodontitis Are Chronic Inflammatory Diseases That May Share Common Immunopathogenic Pathways. TNF-α, IL-17A, and YKL-40 Are Inflammatory Biomarkers Associated With Both Conditions. This Study Aims to Evaluate the Levels of These Markers in Saliva and Serum of Individuals With Psoriasis, Considering Their Periodontal Status, to Investigate a Potential Link Between the Two Diseases
-
CLINICAL_TRIALS study record update · 2025-05-20A Randomized, Active-Controlled, Efficacy Assessor-Blinded Study to Evaluate Pharmacokinetics, Safety and Efficacy of Risankizumab in Patients From 6 to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2025-05-14T Cell Repertoire Analysis of Immune Mediated Skin Diseases
-
CLINICAL_TRIALS study record update · 2025-05-14Exploration of the Cellular and Molecular Mechanisms in Patients Receiving Biotherapies Targeting the IL-23/IL-17 Axis in Cutaneous Psoriasis
-
CLINICAL_TRIALS study record update · 2025-05-13Assessment at 4.5 Months of the Effect of a Dermatology-Oriented Spa Therapy on the Quality of Life of Patients With Psoriasis (BAREGES)